Vancomycin-Resistant Entrococci colonization in chronic hemodialysis patients and its risk factors in southern Iran (2005-2006)

AUTHORS

S Shaghaghian 1 , B Pourabbas 2 , A Alborzi 2 , * , M Askarian 1

1 Community department of Shiraz University of Medical Sciences, Iran

2 Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, [email protected], Iran

How to Cite: Shaghaghian S, Pourabbas B, Alborzi A, Askarian M. Vancomycin-Resistant Entrococci colonization in chronic hemodialysis patients and its risk factors in southern Iran (2005-2006), Iran Red Crescent Med J. Online ahead of Print ; 14(10):686-91.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 14 (10); 686-91
Published Online: October 30, 2012
Article Type: Brief Report
Received: May 30, 2011
Accepted: January 11, 2012

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Vancomycin-resistant enterococci (VRE) recently have emerged as a nosocomial pathogen among dialysis patients. This study aims to appraise the prevalence, incidence density and risk factors for VRE colonization among these patients.

Methods: In this prospective study, 782 stool or rectal swab specimens were collected from 250 chronic hemodialysis patients with an interval of at least one month. To identify the risk factors of VRE colonization, demographic and health data of VRE+ and VRE- patients were compared.

Results: VRE colonization was detected in 55 (22%) patients during study. Incidence density of one case per 79.6 patient-month of follow up was estimated.The only significant difference between the data collected from VRE+ and VRE- patients was observed in antibiotic consumption (P<0.001).

Conclusion: VRE colonization is relatively high and rapidly spreading among chronic dialysis patients. It is strongly associated with recently antibiotic consumption.

Keywords

Vancomycin Resistant Entrococci Hemodialysis Risk Factor Iran

© 2012, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: